Background We assessed the effectiveness of the quadrivalent human papillomavirus
vaccine (qHPV) vaccination program in Manitoba, Canada, in reducing incident anogenital …

In Québec province in Canada, a public school‐based and catch‐up HPV vaccination
programs with the quadrivalent vaccine have been introduced in September 2008 for girls …

Background The incidence of anogenital warts (AGW) decreased after the introduction of the
quadrivalent human papillomavirus (qHPV) vaccine in multiple jurisdictions. We studied how …

Background Assessing the impact and effectiveness of HPV vaccines on anogenital warts in
the United States can provide early indication of the success of vaccination programs as well …

Introduction This study aimed to evaluate the early population impact of Ontario's school-
based human papillomavirus (HPV) vaccination program, implemented in September 2007 …

Background In 2008, British Columbia (BC) implemented a school-based quadrivalent
human papillomavirus (HPV-4) immunization program for girls born in 1994 or later. In 2015 …

Objective The aim of the study was to investigate the effects of 3 or less quadrivalent human
papillomavirus (HPV) vaccine doses on anogenital warts in both males and females in the …

Background Studies in countries with high human papillomavirus (HPV) vaccination
coverage have demonstrated marked reductions in anogenital wart (AGW) incidence. Our …

Background: A vaccine has recently been licensed in many countries that protects against
the human papillomavirus types 6, 11, 16, and 18. Types 6 and 11 account for approximately …

Objective: This study aimed to determine if the Australian human papillomavirus (HPV)
vaccination programme has had a population impact on presentations of genital warts …